The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent

Blood

Volumn 88, Issue 6, 1996, Pages 2093-2100

  Bajzar, Laszlo ^b   Nesheim, Michael E ^b   Tracy, Paula B ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 GUANIDINOTHIAZOLE DERIVATIVE; ACTIVATED PROTEIN C; CARBOXYPEPTIDASE; ENZYME INHIBITOR; MONOCLONAL ANTIBODY; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; PLASMA; PRIORITY JOURNAL;

EID: 0029793068     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2093.bloodjournal8862093     Document Type: Article

References (42)

1. Shafer JA, Higgins DL: Human fibrinogen. CRC Crit Rev Clin Lab Sci 26:1, 1988
2. Mann KG, Jenny RJ, Krishnaswamy S: Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 57:915, 1988
3. Nesheim ME, Taswell JB, Mann KG: The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 254:10952, 1979
4. Bachmann F: Fibrinolysis, in Verstraete M, Vermylen J, Lijnen R, Arnout J (eds): Thrombosis and Haemostasis. Leuven, Belgium, Leuven University, 1987, p 227
5. Suenson E, Lutzen O, Thorsen S: Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem 140:513, 1984
6. Walker FJ, Fay PJ: Regulation of blood coagulation by the protein C system. FASEB J 6:2561, 1992
7. Esmon CT, Johnson AE, Esmon NL: Initiation of the protein C pathway. Ann NY Acad Sci 614:30, 1991
8. Bajzar L, Nesheim M: The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation. J Biol Chem 268:8608, 1993
9. von dem Borne PAKr, Meijers JCM, Bouma BN: Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 86:3035, 1995
10. Bajzar L, Manuel R, Nesheim ME: Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor. J Biol Chem 270:14477, 1995
11. Hendriks D, Wang W, Scharpe S, Lommaert MP, van Sande M: Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim Biophys Acta 1034:86, 1990
12. Eaton DL, Malloy BE, Tsai SP, Henzel W, Drayna D: Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem 269:21833, 1991
13. Redlitz A, Tan AK, Eaton DL, Plow EF: Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Invest 96:2534, 1995
14. Bajzar L, Morser J, Nesheim ME: TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 271:16603, 1996
15. Taylor FB, Lockhart MS: Whole blood clot lysis: In vitro modulation by activated protein C. Thromb Res 37:639, 1985
16. Bajzar L, Fredenburgh JC, Nesheim ME: The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system. J Biol Chem 265:16948, 1990
17. de Fouw NJ, Haverkate F, Bertina RM: Protein C and fibrinolysis: A link between coagulation and fibrinolysis. Adv Exp Med Biol 281:235, 1990
18. Barenholz Y, Gibbes D, Litman BJ, Goll J, Thompson TE, Carlson FD: A simple method for the preparation of homogeneous phospholipid vesicle. Biochemistry 16:2806, 1977
19. Lundblad RL, Kingdon HS, Mann KG: Thrombin. Methods Enzymol 45:156, 1976
20. Mann KG, Elion J, Butkowski RJ, Downing M, Nesheim ME: Prothrombin. Methods Enzymol 80:286, 1981
21. Kohler S, Howe SG, Milsein C: Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol 6:292, 1976
22. Oi VT: Immunoglobulin-producing hybrid cell lines, in Herzenburg LA (ed): Selected Methods in Cellular Biology. San Francisco, CA, Freeman, 1980, chapter 17
23. Church WR, Brown SA, Mason AB: Monoclonal antibodies to the amino- and carboxyl-terminal domains of ovotransferrin. Hybridoma 7:471, 1988
24. Church WR, Ouellett LA, Messier TL: Modulation of human prothrombin activation on phospholipid vesicles and platelets using monoclonal antibodies to prothrombin fragment 2. J Biol Chem 266:8384, 1991
25. March SC, Parikh I, Cuatrecasas P: A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem 60:149, 1974
26. Tijssen P, Kurstak E: Highly efficient and simple methods for the preparation of peroxidase and active peroxidase-antibody conjugates for enzyme immuno assays. Anal Biochem 136:451, 1984
27. Neville DM: Molecular weight determination of protein-dodecyl; sulfate complexes by gel electrophoresis in a siscontinuous buffer system. J Biol Chem 246:6328, 1971
28. Towbin H, Staehlin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350, 1979
29. Weinstein RE, Walker FJ: Species specificity of the fibrinolytic effects of activated protein C. Thromb Res 63:123, 1991
30. Comp PC, Esmon CT: Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 68:1221, 1981
31. Burdick MD, Schaub RG: Human protein C induces anticoagulation and increased fibrinolytic activity in the cat. Thromb Res 45:413, 1987
32. de Fouw NJ, van Hinsbergh VWM, de Jong YF, Haverkate F, Bertina RM: The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from human endothelial cells. Thromb Haemost 57:176, 1987
33. Sakata Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin JH: Mechanism of protein C-dependent clot lysis: Role of plasminogen activator inhibitor. Blood 68:1218, 1986
34. D'Angelo A, Lockhart MS, D'Angelo SV, Taylor FB Jr: Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activation released from platelets. Blood 69:231, 1987
35. de Fouw NJ, de Jong YF, Haverkate F, Bertina RM: Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor - No evidence for a cofactor role of protein S. Thromb Haemost 60:328, 1988
36. de Fouw NJ, de Jong YF, Haverkate F, Bertina RM: The influence of thrombin and platelets on fibrin clot lysis rates in vitro: A study using a clot lysis system consisting of purified human proteins. Fibrinolysis 2:235, 1988
37. van Hinsbergh VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeis JJ, Haverkate F: Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 65:444, 1985
38. Fay WP, Owen WG: Platelet plasminogen activator inhibitor: Purification and characterization of interaction with plasminogen activators and activated protein C. Biochemistry 28:5773, 1989
39. Electricwala A, Atkinson T: Stimulatory effect of hirudin on t-PA induced clot lysis in vitro. Fibrinolysis 4:121, 1990 (abstr)
40. Vlasuk GP, Sitko DR, Smith DE, Shebuski RJ: Effect of selective factor Xa inhibition on the rate and incidence of EPA-induced reprofusion in a canine model of coronary arterial thrombosis. Fibrinolysis 4:8, 1990 (suppl 3)
41. Taylor FB, Carroll RC, Gerrard J, Esmon CT, Radcliffe RD: Lysis of clots prepared from whole blood and plasma. FASEB J 40:2092, 1981
42. Collen D: Towards improved thrombolytic therapy. Lancet 342:34, 1993